CIOMS Working Group on research ethicsAt its 78th Executive Committee Meeting in November 2011, CIOMS decided to initiate a review procedure of its Guidelines on Ethics in Biomedical Research published in 2002. The Guidelines are globally distributed and widely used.



Considering changes in the field of research and developments within research ethics and in order to provide proper guidance to the users of the CIOMS guidelines, they should be up to date and reflect the current state of the art in research ethics.

International Ethical Guidelines for Biomedical Research Involving Human SubjectsMany new points taken on board in the epidemiological guidelines of CIOMs published 2009 need also to be included in revised CIOMS guidelines.  These include: (1) conflict of interest; (2) research using the Internet; and (3) epidemiological research close to or overlapping with "biomedical".

In addition, the revision of the Declaration of Helsinki together with the changes in other relevant documents do constitute a compelling reason for a revision.

New Books



Practical Approaches to Risk Minimisation for Medicinal Products: Report of CIOMS Working Group IX  

The Council for International Organizations of Medical Sciences (CIOMS) announces the publication...

Read more...

 

New Meetings

7th Working Group on MedDRA, Geneva, Switzerland, 19-20 May 2015

9th Working Group on Revision of CIOMS International Ethical Guidelines, Paris, France, 14-16 June 2015

8th Working Group X on Meta-analysis, New Brunswick, NJ, USA, 1-2 July 2015

82nd Executive Committee meeting, Geneva, Switzerland, 8 December 2015

Recent Meetings

6th Vaccine Safety Working Group, Lyon, France, 18-19 March 2015

8th Working Group on Revision of CIOMS International Ethical Guidelines, Vilnius, Lithuania, 22-24 March 2015

81st CIOMS Executive Committee Meeting, Geneva, Switzerland, 18 November 2014

7th Working Group on Revision of CIOMS International Ethical Guidelines, Geneva, Switzerland, 12-14 November 2014

5th Vaccine Safety Working Group, Rabat, Morocco, 24-25 September 2014

8th Working Group X on Meta-analysis, Basel, Switzerland, 30 September – 1 October 2014

MedDRA 6th IWG Meeting, ICH, Geneva, Switzerland, 14-16 October 2014

6th Working Group on Revision of CIOMS International Ethical Guidelines, Geneva, Switzerland, 21-23 May 2014

4th Vaccine Safety Working Group, UMC, Uppsala, Sweden, 20-21 May 2014

5th Working Group on MedDRA, ICH, Geneva, Switzerland, 9-10 April 2014

5th Working Group on Revision of CIOMS International Ethical Guidelines, Utrecht, Netherlands, 26-28 February 2014

7th Working Group X on Meta-analysis, Durham, North Carolina, USA, 25-26 February 2014

3rd Vaccine Safety Working Group, CDC, Atlanta, GA, USA, 5-6 February 2014

CIOMS 80th Executive Committee Meeting, XXI General Assembly & Workshop, 20 November 2013, WHO Headquarters, Geneva, Switzerland

CIOMS 4th Working Group on Revision of CIOMS International Ethical Guidelines, 17-19 November 2013, WHO Headquarters, Geneva, Switzerland

CIOMS Working Group on Vaccine Safety, 17-18 September  2013, WHO Headquarters, Geneva, Switzerland

CIOMS WG X on Considerations for applying good meta-analysis practices to clinical safety data within the biopharmaceutical regulatory process, 12-13 September 2013, Singapore

CIOMS Working Group on the Review of 2002 International Ethical Guidelines, 26-28 June 2013, UMC, Utrecht, The Netherlands

CIOMS WG on Vaccine Safety, 29-30 May 2013 , EMA, London, UK

CIOMS Working Group on the Review of 2002 International Ethical Guidelines, 11-12 February 2013, Geneva, Switzerland

CIOMS Working Group X, 14-15 March 2013, MEB, Utrecht, The Netherlands

CIOMS Working Group IX, 18-19 March 2013, NDA, Stockholm, Sweden

MedDRA 3rd IWG Meeting, 9-10 April 2013, IFPMA/CIOMS, Geneva, Switzerland

WHO on Twitter
WHO 24-30 April is World Immunization Week! Close the immunization gap! http://t.co/W79kcHd0i4 #VaccinesWork http://t.co/6hHbWNInej
16h
WHO The #openaccess is aimed to improve patient safety, increase transparency, encourage reporting of adverse effects from medicinal products
17h
WHO WHO provides #openaccess to the WHO Global Medicines Safety Database http://t.co/nDd7hLCcrD
17h
WHO W/ limited access thru air & sea ports into #Yemen, local meds stocks are being rapidly depleted as the needs on the ground continue to grow
WHO Shortages include a lack of medicines and supplies for managing chronic diseases in #Yemen http://t.co/fVhfeT0aDS

Visitors

838421

Member Login